M9179
Meglumine
99.0-100.5% dry basis, meets USP testing specifications
Synonym(s):
N-Methyl-D-glucamine, 1-Deoxy-1-(methylamino)-D-glucitol, Meglumine
Sign Into View Organizational & Contract Pricing
Select a Size
All Photos(1)
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C7H17NO5
CAS Number:
Molecular Weight:
195.21
Beilstein/REAXYS Number:
385906
EC Number:
MDL number:
UNSPSC Code:
12352104
PubChem Substance ID:
NACRES:
NA.21
Recommended Products
biological source
synthetic (organic)
Quality Level
agency
USP/NF
meets USP testing specifications
assay
99.0-100.5% dry basis
form
powder
autoignition temp.
~662 °F
color
off-white
mp
129-131.5 °C (lit.)
solubility
water: soluble
application(s)
pharmaceutical (small molecule)
Looking for similar products? Visit Product Comparison Guide
Application
- Pentavalent Antimony Associated with G-CSF in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis: Investigates the use of meglumine in conjunction with G-CSF, showing potential for enhanced treatment outcomes (Suprien et al., 2024).
Other Notes
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
Storage Class
11 - Combustible Solids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Philipp Kickingereder et al.
Neuro-oncology, 17(8), 1139-1147 (2015-03-11)
To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB). A total of 127 patients diagnosed with rGB receiving either bevacizumab
Raphaëlle Renard-Penna et al.
Radiology, 275(2), 458-468 (2015-01-20)
To compare the diagnostic performance of the magnetic resonance (MR) imaging-based Prostate Imaging Reporting and Data System (PI-RADS) and a Likert scale in the detection of prostate cancer in a cohort of patients undergoing initial prostate biopsy. This institutional review
Andrea Barison et al.
Journal of cardiovascular medicine (Hagerstown, Md.), 16(10), 681-687 (2015-06-20)
In nonischaemic dilated cardiomyopathy (NICM), replacement myocardial fibrosis as detected by late gadolinium enhancement (LGE) at cardiovascular magnetic resonance (CMR) is associated with poor prognosis. We investigated the as-yet unexplored prognostic significance of interstitial fibrosis in NICM, using T1-mapping CMR.
Alexander Radbruch et al.
Radiology, 275(3), 783-791 (2015-04-08)
To compare changes in signal intensity (SI) ratios of the dentate nucleus (DN) and the globus pallidus (GP) to those of other structures on unenhanced T1-weighted magnetic resonance (MR) images between linear and macrocyclic gadolinium-based contrast agents (GBCAs). The study
Charlotte Manisty et al.
Radiology, 276(3), 732-740 (2015-04-30)
To investigate the pharmacology and potential clinical utility of splenic switch-off to identify understress in adenosine perfusion cardiac magnetic resonance (MR) imaging. Splenic switch-off was assessed in perfusion cardiac MR examinations from 100 patients (mean age, 62 years [age range
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service